Polycythemia vera; current status. 1956

C F STROEBEL

UI MeSH Term Description Entries
D011087 Polycythemia Vera A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs. Erythremia,Osler-Vaquez Disease,Polycythemia Rubra Vera,Polycythemia Ruba Vera,Primary Polycythemia,Disease, Osler-Vaquez,Erythremias,Osler Vaquez Disease,Polycythemia Ruba Veras,Polycythemia Rubra Veras,Polycythemia, Primary,Polycythemias, Primary,Primary Polycythemias,Ruba Vera, Polycythemia,Ruba Veras, Polycythemia,Vera, Polycythemia Ruba,Vera, Polycythemia Rubra,Veras, Polycythemia Ruba,Veras, Polycythemia Rubra
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C F STROEBEL
October 2000, Deutsche medizinische Wochenschrift (1946),
C F STROEBEL
May 2001, Deutsche medizinische Wochenschrift (1946),
C F STROEBEL
January 2002, Leukemia & lymphoma,
C F STROEBEL
January 2001, Seminars in hematology,
C F STROEBEL
July 2020, Expert opinion on therapeutic targets,
C F STROEBEL
December 1980, La Clinica terapeutica,
C F STROEBEL
April 2013, Expert opinion on pharmacotherapy,
C F STROEBEL
October 2005, Seminars in hematology,
C F STROEBEL
August 2018, Turkish journal of medical sciences,
C F STROEBEL
May 1974, Postgraduate medicine,
Copied contents to your clipboard!